Top Markets
Coin of the day
Abnova (Taiwan) Corporation Abnova (Taiwan) Corporation

Abnova (Taiwan) Corporation

4133
주식 순위 #26488
Abnova (Taiwan) Corporation specializes in the development and distribution of... Abnova (Taiwan) Corporation specializes in the development and distribution of a comprehensive range of recombinant proteins and antibodies. The company's extensive product portfolio caters to diverse research and diagnostic applications, featuring specialized reagents for SARS-CoV/CoV-2, nucleic acids (both DNA and RNA), and various proteins and peptides. Their offerings further include items like DNAxPab, laboratory beads, dyes, cellular lysates, microscopic slides, antibody pairs and associated kits, as well as antibody and tissue arrays. Additionally, they provide in situ hybridization products, advanced laboratory systems and automation, GMP-grade and analyte-specific reagents, and solutions for in vitro diagnostics. Beyond these product lines, Abnova supplies a broad spectrum of antibody types, such as MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and those specifically targeting circulating rare cells. The company also delivers integrated solutions and services, encompassing gene synthesis and cytogenetic analysis, peptide services, protein expression and conjugations, custom antibody generation, and assay development. Abnova (Taiwan) Corporation operates from its headquarters in Taipei, Taiwan.
주가
$0.66300973
시가총액
$40.15M
변동 (1일)
1.46%
변동 (1년)
-20.61%
국가
TW
거래 Abnova (Taiwan) Corporation (4133)

카테고리

Abnova (Taiwan) Corporation (4133)의 주가 이력
최고 종가: $0.66 (2026-08-01 기준)

최저 종가: $3.41 (2009-12-01 기준)
Abnova (Taiwan) Corporation의 주가 이력 (2009 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 1.85%
2025 -17.49%
2024 -22.72%
2023 -10.67%
2022 -14.11%
2021 -27.76%
2020 140.17%
2019 -10.70%
2018 -23.38%
2017 12.35%
2016 13.13%
2015 -4.28%
2014 -28.11%
2013 -11.24%
2012 18.97%
2011 -55.17%
2010 -11.07%
2009 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$539.14 36.71%
US
$1.04K 56.86%
NL
$120.74 -14.98%
AU
$761.87 7.04%
CH
$130.43 385.07%
US